216 related articles for article (PubMed ID: 30777782)
1. Development of prediction model for fructose- 1,6- bisphosphatase inhibitors using the Monte Carlo method.
Manisha ; Chauhan S; Kumar P; Kumar A
SAR QSAR Environ Res; 2019 Mar; 30(3):145-159. PubMed ID: 30777782
[TBL] [Abstract][Full Text] [Related]
2. Use of Graph Based Descriptors for Determination of Structural Features Causing Modulation of Fructose-1,6-Bisphosphatase.
Kumar A; ; Bagri K; Kumar P
Drug Res (Stuttg); 2020 May; 70(5):226-232. PubMed ID: 32246452
[TBL] [Abstract][Full Text] [Related]
3. Monte Carlo method based QSAR modelling of natural lipase inhibitors using hybrid optimal descriptors.
Kumar A; Chauhan S
SAR QSAR Environ Res; 2017 Mar; 28(3):179-197. PubMed ID: 28271914
[TBL] [Abstract][Full Text] [Related]
4. Design and development of novel focal adhesion kinase (FAK) inhibitors using Monte Carlo method with index of ideality of correlation to validate QSAR.
Kumar P; Kumar A; Sindhu J
SAR QSAR Environ Res; 2019 Feb; 30(2):63-80. PubMed ID: 30793981
[TBL] [Abstract][Full Text] [Related]
5. Protein-based alignment in 3D-QSAR of FBPase inhibitors.
Yi P; Di YT; Liu W; Hao XJ; Ming Y; Huang DS; Yang J; Yi ZZ; Li ZJ; Yang RD; Zhang JC
Eur J Med Chem; 2011 Mar; 46(3):885-92. PubMed ID: 21269737
[TBL] [Abstract][Full Text] [Related]
6. Monte Carlo QSAR models for predicting organophosphate inhibition of acetycholinesterase.
Veselinović JB; Nikolić GM; Trutić NV; Živković JV; Veselinović AM
SAR QSAR Environ Res; 2015 Jun; 26(6):449-60. PubMed ID: 26043064
[TBL] [Abstract][Full Text] [Related]
7. Use of the Monte Carlo Method for OECD Principles-Guided QSAR Modeling of SIRT1 Inhibitors.
Kumar A; Chauhan S
Arch Pharm (Weinheim); 2017 Jan; 350(1):. PubMed ID: 28025857
[TBL] [Abstract][Full Text] [Related]
8. Use of Simplified Molecular Input Line Entry System and molecular graph based descriptors in prediction and design of pancreatic lipase inhibitors.
Kumar A; Chauhan S
Future Med Chem; 2018 Jul; 10(13):1603-1622. PubMed ID: 30028205
[TBL] [Abstract][Full Text] [Related]
9. In silico design of diacylglycerol acyltransferase-1 (DGAT1) inhibitors based on SMILES descriptors using Monte-Carlo method.
Kumar P; Kumar A; Sindhu J
SAR QSAR Environ Res; 2019 Aug; 30(8):525-541. PubMed ID: 31331203
[TBL] [Abstract][Full Text] [Related]
10. coral Software: QSAR for Anticancer Agents.
Benfenati E; Toropov AA; Toropova AP; Manganaro A; Gonella Diaza R
Chem Biol Drug Des; 2011 Jun; 77(6):471-6. PubMed ID: 21435183
[TBL] [Abstract][Full Text] [Related]
11. In silico identification of structure requirement for novel thiazole and oxazole derivatives as potent fructose 1,6-bisphosphatase inhibitors.
Hao M; Zhang X; Ren H; Li Y; Zhang S; Luo F; Ji M; Li G; Yang L
Int J Mol Sci; 2011; 12(11):8161-80. PubMed ID: 22174657
[TBL] [Abstract][Full Text] [Related]
12. In silico prediction of the β-cyclodextrin complexation based on Monte Carlo method.
Veselinović AM; Veselinović JB; Toropov AA; Toropova AP; Nikolić GM
Int J Pharm; 2015 Nov; 495(1):404-409. PubMed ID: 26320546
[TBL] [Abstract][Full Text] [Related]
13. CORAL: Monte Carlo based global QSAR modelling of Bruton tyrosine kinase inhibitors using hybrid descriptors.
Ahmadi S; Lotfi S; Afshari S; Kumar P; Ghasemi E
SAR QSAR Environ Res; 2021 Dec; 32(12):1013-1031. PubMed ID: 34875951
[TBL] [Abstract][Full Text] [Related]
14. Monte Carlo method based QSAR modeling of maleimide derivatives as glycogen synthase kinase-3β inhibitors.
Živković JV; Trutić NV; Veselinović JB; Nikolić GM; Veselinović AM
Comput Biol Med; 2015 Sep; 64():276-82. PubMed ID: 26257010
[TBL] [Abstract][Full Text] [Related]
15. Monte carlo method-based QSAR modeling of penicillins binding to human serum proteins.
Veselinović JB; Toropov AA; Toropova AP; Nikolić GM; Veselinović AM
Arch Pharm (Weinheim); 2015 Jan; 348(1):62-7. PubMed ID: 25408278
[TBL] [Abstract][Full Text] [Related]
16. Hydroxyethylamine derivatives as HIV-1 protease inhibitors: a predictive QSAR modelling study based on Monte Carlo optimization.
Bhargava S; Adhikari N; Amin SA; Das K; Gayen S; Jha T
SAR QSAR Environ Res; 2017 Dec; 28(12):973-990. PubMed ID: 29072112
[TBL] [Abstract][Full Text] [Related]
17. Good and bad molecular fingerprints for human rhinovirus 3C protease inhibition: identification, validation, and application in designing of new inhibitors through Monte Carlo-based QSAR study.
Jain S; Amin SA; Adhikari N; Jha T; Gayen S
J Biomol Struct Dyn; 2020 Jan; 38(1):66-77. PubMed ID: 30646829
[TBL] [Abstract][Full Text] [Related]
18. QSAR models for HEPT derivates as NNRTI inhibitors based on Monte Carlo method.
Toropova AP; Toropov AA; Veselinović JB; Miljković FN; Veselinović AM
Eur J Med Chem; 2014 Apr; 77():298-305. PubMed ID: 24657566
[TBL] [Abstract][Full Text] [Related]
19. The Application of the Combination of Monte Carlo Optimization Method based QSAR Modeling and Molecular Docking in Drug Design and Development.
Zivkovic M; Zlatanovic M; Zlatanovic N; Golubović M; Veselinović AM
Mini Rev Med Chem; 2020; 20(14):1389-1402. PubMed ID: 32048970
[TBL] [Abstract][Full Text] [Related]
20. Fructose-1,6-bisphosphatase inhibitors: A new valid approach for management of type 2 diabetes mellitus.
Kaur R; Dahiya L; Kumar M
Eur J Med Chem; 2017 Dec; 141():473-505. PubMed ID: 29055870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
